Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance-Reference-Cited by-同舟云学术

Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance

Published:2020-03-10 Issue:5 Volume:19 Page:1110-1122
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Dahn Margaret L.,Cruickshank Brianne M.,Jackson Ainsleigh J.,Dean Cheryl,Holloway Ryan W.,Hall Steven R.,Coyle Krysta M.^ORCID,Maillet Hillary,Waisman David M.,Goralski Kerry B.^ORCID,Giacomantonio Carman A.,Weaver Ian C.G.^ORCID,Marcato Paola

Funder

Cancer Research Society

Institute of Cancer Research

Canadian Institutes of Health Research

Natural Sciences and Engineering Research Council of Canada

CIHR

Nova Scotia Health Research Foundation

Killam Laureate scholarship

Nova Scotia Research and Innovation Graduate

Killam Laureate scholarships

Dalhousie Medical Research Foundation

TCGA Research Network

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Cytotoxicity of Histone Deacetylase and Poly-ADP Ribose Polymerase Inhibitors and Decitabine in Breast and Ovarian Cancer Cells: Implications for Novel Therapeutic Combinations;International Journal of Molecular Sciences;2024-08-26

2. Beyond the Usual Suspects: Examining the Role of Understudied Histone Variants in Breast Cancer;International Journal of Molecular Sciences;2024-06-20

3. Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment;Pharmacological Research;2024-06

4. Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection;Breast Cancer Research;2024-05-14

5. RETRACTED ARTICLE: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine;Clinical Epigenetics;2024-01-22